Cargando…
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system
INTRODUCTION: We have recently synthesized phospho-ibuprofen (P-I; MDC-917), a safer derivative of ibuprofen, which has shown anti-cancer activity. We investigated its efficacy and mechanism of action in the treatment of breast cancer in preclinical models. METHODS: We evaluated the anti-breast-canc...
Autores principales: | Sun, Yu, Rowehl, Leahana M, Huang, Liqun, Mackenzie, Gerardo G, Vrankova, Kvetoslava, Komninou, Despina, Rigas, Basil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496138/ https://www.ncbi.nlm.nih.gov/pubmed/22293394 http://dx.doi.org/10.1186/bcr3105 |
Ejemplares similares
-
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
por: Mackenzie, Gerardo G., et al.
Publicado: (2013) -
Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress
por: Huang, Liqun, et al.
Publicado: (2014) -
Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
por: MURRAY, ONIKA T., et al.
Publicado: (2013) -
Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect
por: Huang, Liqun, et al.
Publicado: (2014) -
Phospho-valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles
por: Mattheolabakis, George, et al.
Publicado: (2017)